71
US okays Moderna’s ‘next generation’ Covid-19 vaccine
The new vaccine, mNexspike (mRNA-1283), is a step toward next-generation coronavirus vaccines. It’s made in a way that allows for a lower dose, a fifth of the dose of its current COVID-19 vaccine, Spikevax (mRNA-1273) by refining its immune target
Moderna logo is seen displayed in this illustration taken, May 3, 2022. REUTERS
Discover more from Now World View
Subscribe to get the latest posts sent to your email.